2238 Schneider, Jay S. - Jefferson Medical College - Thomas Jefferson University
jss101

Jay S. Schneider, PhD

Contact Dr. Schneider

1020 Locust Street
Jefferson Alumni Hall, Suite 521
Philadelphia, PA 19107

(215) 503-0370

Most Recent Peer-reviewed Publications

  1. Effects of memantine and galantamine on cognitive performance in aged rhesus macaques
  2. Influence of developmental lead exposure on expression of DNA methyltransferases and methyl cytosine-binding proteins in hippocampus
  3. A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
  4. Levodopa improves motor deficits but can further disrupt cognition in a macaque parkinson model
  5. Sex and rearing condition modify the effects of perinatal lead exposure on learning and memory
  6. Effects of developmental lead exposure on the hippocampal transcriptome: Influences of sex, developmental period, and lead exposure level
  7. Impaired spatial working memory learning and performance in normal aged rhesus monkeys
  8. Differential effect of postnatal lead exposure on gene expression in the hippocampus and frontal cortex
  9. Behavioral toxicology of cognition: Extrapolation from experimental animal models to humans. Behavioral toxicology symposium overview
  10. Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
  11. Sex-based differences in gene expression in hippocampus following postnatal lead exposure
  12. Effects of the alpha-2 adrenoceptor agonist guanfacine on attention and working memory in aged non-human primates
  13. Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system
  14. Attention, executive functioning and memory in normal aged rhesus monkeys
  15. Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates
  16. Protection of dopaminergic cells from MPP +-mediated toxicity by histone deacetylase inhibition
  17. The dopamine D 3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures
  18. Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience
  19. Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism
  20. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats
0